Measurable Residual Disease Monitoring by Multiparameter Flow Cytometry and Relapse Prediction in Adult Acute Myeloid Leukemia. ALR [Internet]. 2024 Aug. 12 [cited 2026 Oct. 31];5(1):1-6. Available from: https://somatopub.com/index.php/ALR/article/view/324